Pharmsintez's RAS loss for 9 months of 2023 amounted to ₽191.61 million, up 13.3% from ₽169.11 million in the previous year. Revenue declined 25.9% to ₽183.12 million against ₽247.05 million a year earlier.
Warning BlackTerminal uses cookies in order to personalize and improve the usability of the service. If you do not want to use cookies, please change your browser settings. Accept